The Optimal Percutaneous Coronary Intervention Strategy for Patients with ST-segment Elevation Myocardial Infarction and Multivessel Disease: a Pairwise and Network Meta-analysis

Overview

Journal Ther Adv Chronic Dis

Publisher Sage Publications

Date 2022 Mar 17

PMID 35295615

Authors

Meng-Jin Hu

Jiang-Shan Tan

Wen-Yang Jiang

Xiao-Jin Gao

Yue-Jin Yang

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the optimal percutaneous coronary intervention (PCI) strategy in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease.

Methods: Trials that randomized patients with STEMI and multivessel coronary artery disease to immediate multivessel PCI, staged multivessel PCI, or culprit-only PCI and prospective observational studies that investigated all-cause death were included. Random effect risk ratio (RR) and 95% confidence interval (CI) were calculated.

Results: A total of 13 randomized trials with 7627 patients and 21 prospective observational studies with 60311 patients were included. In the pairwise and network meta-analysis based on randomized trials, immediate or staged multivessel PCI was associated with a lower risk of long-term major adverse cardiac events (MACE; RR: 0.58; 95% CI: 0.45 to 0.74) than culprit-only PCI, which was mainly due to lower risks of myocardial infarction (RR: 0.67; 95% CI: 0.51 to 0.88) and revascularization (RR: 0.38; 95% CI: 0.28 to 0.51), without any significant difference in all-cause death (RR: 0.85; 95% CI: 0.69 to 1.04; = 0.0%). However, short-term outcomes were deficient in randomized trials. The results from real-world prospective observational studies suggested that staged multivessel PCI reduced long-term all-cause death (RR: 0.53; 95% CI: 0.39 to 0.71; = 15.6%), whereas immediate multivessel PCI increased short-term all-cause death (RR: 1.58; 95% CI: 1.22 to 2.05; = 43.8%) relative to culprit-only PCI.

Conclusion: For patients in randomized trials, multivessel PCI in an immediate or staged procedure was preferred due to improvements in long-term outcomes. As a supplement, the results in real-world patients derived from prospective observational studies suggested that staged multivessel PCI was superior to immediate multivessel PCI. Therefore, staged multivessel PCI may be the optimal PCI strategy for patients with STEMI and multivessel coronary artery disease.

Citing Articles

Top Five Stories of the Cellular Landscape and Therapies of Atherosclerosis: Current Knowledge and Future Perspectives.

Pan Q, Chen C, Yang Y Curr Med Sci. 2023; 44(1):1-27.

PMID: 38057537 DOI: 10.1007/s11596-023-2818-2.

References

Kornowski R, Mehran R, Dangas G, Nikolsky E, Assali A, Claessen B . Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol. 2011; 58(7):704-11. DOI: 10.1016/j.jacc.2011.02.071. View

Xu H, Yang Y, Wang C, Yang J, Li W, Zhang X . Association of Hospital-Level Differences in Care With Outcomes Among Patients With Acute ST-Segment Elevation Myocardial Infarction in China. JAMA Netw Open. 2020; 3(10):e2021677. PMC: 7584928. DOI: 10.1001/jamanetworkopen.2020.21677. View

Gershlick A, Khan J, Kelly D, Greenwood J, Sasikaran T, Curzen N . Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015; 65(10):963-72. PMC: 4359051. DOI: 10.1016/j.jacc.2014.12.038. View

Damman P, van t Hof A, Ten Berg J, Jukema J, Appelman Y, Liem A . 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group. Neth Heart J. 2016; 25(3):181-185. PMC: 5313450. DOI: 10.1007/s12471-016-0939-y. View

Hanratty C, Koyama Y, Rasmussen H, Nelson G, Hansen P, Ward M . Exaggeration of nonculprit stenosis severity during acute myocardial infarction: implications for immediate multivessel revascularization. J Am Coll Cardiol. 2002; 40(5):911-6. DOI: 10.1016/s0735-1097(02)02049-1. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Bainey K, Engstrom T, Smits P, Gershlick A, James S, Storey R . Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis. JAMA Cardiol. 2020; 5(8):881-888. PMC: 7240651. DOI: 10.1001/jamacardio.2020.1251. View

Halvorsen S, Seljeflot I, Weiss T, Bohmer E, Arnesen H . Inflammatory and thrombotic markers in patients with ST-elevation myocardial infarction treated with thrombolysis and early PCI: a NORDISTEMI substudy. Thromb Res. 2012; 130(3):495-500. DOI: 10.1016/j.thromres.2012.04.016. View

Ghani A, Dambrink J, van t Hof A, Ottervanger J, Gosselink A, Hoorntje J . Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial. Neth Heart J. 2012; 20(9):347-53. PMC: 3430767. DOI: 10.1007/s12471-012-0281-y. View

10.

Wood D, Cairns J, Wang J, Mehran R, Storey R, Nguyen H . Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial. J Am Coll Cardiol. 2019; 74(22):2713-2723. DOI: 10.1016/j.jacc.2019.09.051. View

11.

Elgendy I, Huo T, Mahmoud A, Bavry A . Complete versus culprit-only revascularization in patients with multi-vessel disease undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials. Int J Cardiol. 2015; 186:98-103. DOI: 10.1016/j.ijcard.2015.03.163. View

12.

Klingenberg R, Brokopp C, Grives A, Courtier A, Jaguszewski M, Pasqual N . Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes. Eur Heart J. 2014; 36(17):1041-8. PMC: 4416137. DOI: 10.1093/eurheartj/eht543. View

13.

Pollack A, Mohanty B, Handa R, Looser P, Fuster V, King 3rd S . Preventive stenting in acute myocardial infarction. JACC Cardiovasc Interv. 2015; 8(1 Pt B):131-138. DOI: 10.1016/j.jcin.2014.09.006. View

14.

Higgins J, Thompson S, Deeks J, Altman D . Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. PMC: 192859. DOI: 10.1136/bmj.327.7414.557. View

15.

Di Mario C, Mara S, Flavio A, Imad S, Antonio M, Anna P . Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovasc Intervent. 2005; 6(3-4):128-33. DOI: 10.1080/14628840310030441. View

16.

Anantha Narayanan M, Reddy Y, Sundaram V, Reddy Y, Baskaran J, Agnihotri K . What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - Conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials. Int J Cardiol. 2016; 216:18-24. DOI: 10.1016/j.ijcard.2016.04.054. View

17.

Hamza M, Mahmoud A, Elgendy I . A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients With Acute ST Elevation Myocardial Infarction and Multi Vessel Disease. J Interv Cardiol. 2016; 29(3):241-7. DOI: 10.1111/joic.12293. View

18.

Engstrom T, Kelbaek H, Helqvist S, Hofsten D, Klovgaard L, Holmvang L . Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. Lancet. 2015; 386(9994):665-71. DOI: 10.1016/s0140-6736(15)60648-1. View

19.

Ibanez B, James S, Agewall S, Antunes M, Bucciarelli-Ducci C, Bueno H . 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European.... Eur Heart J. 2017; 39(2):119-177. DOI: 10.1093/eurheartj/ehx393. View

20.

Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R . PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N Engl J Med. 2017; 377(25):2419-2432. DOI: 10.1056/NEJMoa1710261. View